Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 16, 2021

Later deadlines: Nov 16, 2021, Jan 7, 2022

Grant amount: Up to US $275,000

Fields of work: Bioengineering

Applicant type: Organizations

Funding uses: Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: Applications are due by 5pm submitter's local time on the following dates:

  • Non-AIDS Applications:
    • New applications are due on February 16, June 16, and October 16 annually.
    • Renewal applications are due on March 16, July 16, and November 16 annually.
  • AIDS Applications are due on January 7, May 7, and September 7 annually.

The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of Exploratory/Developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed January 10, 2019 and last updated January 10, 2019